InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by McFarlane Neil F., Chairman & CEO. Officer active across 2 companies, notably Adamas Pharmaceuticals Inc. Cumulatively, 4 disclosures have been logged. The latest transaction was disclosed on 19 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
014,035 shares0
Common Stock
SEC:0001062993-22-013303:0·
017,845 shares0
Common Stock
SEC:0001062993-22-010000:0·
075,000 shares0
Common Stock
SEC:0001328143-21-000093·
075,000 shares0
Common Stock
SEC:0001328143-21-000093:0·
4 of 4 declarations
About McFarlane Neil F.
Neil F. McFarlane is the Chief Executive Officer of Adamas Pharmaceuticals Inc and Collegium Pharmaceutical, Inc. As CEO, he leads both companies in the biopharmaceutical sector. McFarlane is responsible for the overall strategy and innovation in developing medical treatments. Under his leadership, the companies are committed to providing high-quality healthcare solutions.
